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patients are dual scanned i.e. IV contrast 3D scan followed by 
non contrast 4DCT.  
Sixty five percent of centres agreed or strongly agreed 
updated guidelines would be useful. 
 
Conclusion: The results suggest adherence to RCR guidelines 
is poor. Very little current evidence exists relating to optimal 
IV contrast protocols both in the UK and internationally. No 
standardised guidelines exist in relation to 4DCT IV contrast 
protocols and timings which in some centres is resulting in 
patients being dual scanned. There are many areas such as 
flow rates, timings and administration in conjunction with 
advanced techniques which require further research to 
enable updated standardised guidelines to be identified. The 
need for updated guidelines is supported by 65% of 
respondents of this study. 
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Purpose or Objective: In image-guided radiotherapy (IGRT) 
for esophageal cancer, it is common to use bony anatomy-
based registration (BR) for setup verification. A recent study, 
in which we investigated fiducial marker-based registration 
relative to BR, indicated marker-based registration to be 
infeasible due to tissue deformation. In the present study, we 
investigated the feasibility and geometric accuracy of carina-
based registration (CR) for CBCT-guided setup verification in 
esophageal cancer IGRT. 
 
Material and Methods: Retrospectively, 24 esophageal 
cancer patients with 65 implanted fiducial markers, visible on 
planning CTs and follow-up CBCTs, were included in this 
study. Fiducial markers were considered as standard for 
tumor position. All available CBCT scans (n=236) were 
independently rigidly registered to the reference CT with 
respect to either the bony anatomy or to the carina using XVI 
software (Elekta Ltd. Crawley) to determine the individual 
marker displacement relative to the bony anatomy and to the 
carina, respectively. Automatic registrations were visually 
checked and manually adjusted when necessary. 
Subsequently, we assessed and compared per individual 
marker the mean marker displacement over the treatment 
course (systematic position error, SE) associated with either 
BR or CR. Markers were classified into four subgroups based 
on their locations in the esophagus (proximal, mid-esophagus, 
distal, cardia) and analysis was similarly as mentioned above 
performed per subgroup. Comparison between both 
registration methods was done using a paired Wilcoxon 
signed-rank test. 
 
Results: The distributions of the absolute mean systematic 
position error of the individual markers relative to the bony 
anatomy and the carina are given in Figure 1.A. Overall, a 
large SE is associated with the use of both bony anatomy and 
carina, especially in the CC direction. Figure 1.B, illustrates 
the slightly favorable use of the BR for proximal located 
markers. Markers located in the mid-esophagus show a 
smaller SE in CC and AP direction when using the CR, 
however this difference was not significant. For markers 
located in the distal esophagus and cardia, the BR is 
favorable in AP direction (p<0.001). Furthermore, the 
majority of the CRs were more challenging given the low 
contrast resolution in comparison with the BRs. 
 
 
 
 
Conclusion: The mean marker displacement (SE), residual 
tumor position error, over the treatment course remains 
large and is in most directions even slightly larger when using 
CR compared with BR. Only for tumors located in the mid-
esophagus the CR can be slightly favorable. However, 
esophageal tumors typically extend across regions and the 
majority of tumors are located distally. Therefore, our data 
endorse the use of BR over CR for setup verification. 
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